Clinical Trial Update: Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating metformin hydrochloride for prevention of breast cancer in women with atypical ductal hyperplasia or in situ breast lesions. Results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Ductal Hyperplasia
• Breast Cancer
• Ductal Carcinoma in Situ
• Lobular Carcinoma in Situ

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-13